Medicare can now cover certain weight loss drugs in a big step for patients

  • 📰 nbcchicago
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

Medicare patients can soon get coverage for Novo Nordisk’s Wegovy as long as it is prescribed to reduce their risk of heart attacks and strokes.

Medicare can start covering certain weight loss drugs – as long as they are approved in the U.S. for an added health benefit.

The agency's guidance will allow Medicare patients to get coverage for Novo Nordisk's weight loss injection Wegovy as long as it is prescribed to reduce their risk of heart attacks and strokes. Feeling out of the loop? We'll catch you up on the Chicago news you need to know. Sign up for the weekly's Wegovy, which is now approved in the U.S. for heart health. Those treatments have skyrocketed in demand over the last year despite their hefty price tags and spotty insurance coverage.

The agency's guidance means Medicare patients could soon get coverage for Wegovy, as long as they have obesity and a history of heart disease and are prescribed the treatment to reduce their risk of heart attacks and strokes. Earlier this month, the Food and Drug Administration approved Wegovy for that purpose.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 545. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Source: Forbes - 🏆 394. / 53 Read more »

FDA approves Novo Nordisk's Wegovy for lowering heart risksThe Food and Drug Administration approved Novo Nordisk's weight-loss drug Wegovy on Friday for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes.
Source: KSLcom - 🏆 549. / 51 Read more »

Patients, Advocates Push Biden to 'Reclaim Medicare' From Privatized Medicare AdvantageJake Johnson is a senior editor and staff writer for Common Dreams.
Source: commondreams - 🏆 530. / 51 Read more »

More teens are using weight loss drugs like Wegovy and OzempicMarina Kopf is an associate producer with the NBC News Health and Medical Unit.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

FDA Approves Wegovy For Heart Conditions in Game-Changing MoveThe Best in Science News and Amazing Breakthroughs
Source: ScienceAlert - 🏆 63. / 68 Read more »

FDA approves weight-loss drug Wegovy to reduce heart-disease risksThe FDA approved the weight-loss drug Wegovy as a treatment to reduce cardiovascular risk in adults who are overweight, the first approval of its kind.
Source: washingtonpost - 🏆 95. / 72 Read more »